Advisory Services Network’s ProKidney PROK Stock Holding History

Advisory Services Network’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-184	Closed	-$445	–	3636
2025 Q3	$445	Buy	+184	New	+$490	﹤0.01%	4067

Other funds holding PROK

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return

Advisory Services Network's PROK Position: Q4 2025 in Review

Advisory Services Network sold out of ProKidney (PROK) in Q4 2025, closing a stake of 184 shares — an estimated $445 sold.

Advisory Services Network first reported a position in PROK in Q3 2025 and held it in 1 quarter. The position peaked at $445 in Q3 2025. 63 funds tracked by Wall St. Rank hold PROK as of Q4 2025.

Advisory Services Network reported no remaining ProKidney position as of Q4 2025 after selling out during the quarter.
Advisory Services Network sold 184 ProKidney shares in Q4 2025, an estimated $445.
Advisory Services Network first reported a position in ProKidney in Q3 2025 and held it in 1 quarter.
Advisory Services Network's ProKidney position peaked at $445 in Q3 2025.
63 funds tracked by Wall St. Rank held ProKidney as of Q4 2025.

Based on Advisory Services Network's 13F filing for Q4 2025, filed 17 Feb 2026.